Rockefeller Capital Management L.P. Homology Medicines, Inc. Transaction History

Rockefeller Capital Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$1.55 - $3.01 $323 - $629	-209 Reduced 2.04%	10,059 $16,000
Q2 2022 Aug 12, 2022	BUY	$1.39 - $3.12 $290 - $652	209 Added 2.08%	10,268 $20,000
Q4 2020 Feb 12, 2021	BUY	$8.92 - $13.29 $89,200 - $132,900	10,000 Added 16949.15%	10,059 $113,000
Q2 2020 Aug 12, 2020	BUY	$12.07 - $19.34 $712 - $1,141	59 New	59 $1,000
Q1 2020 May 12, 2020	SELL	$12.5 - $22.04 $2,187 - $3,857	-175 Closed	0 $0

Q1 2019 May 10, 2019	BUY	$19.76 - $29.57 $3,458 - $5,174	175 New	175 $5,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.